# Risk: __Inadequate surveillance measures__ (PBN__Risk_1513)

## Property: has_RiskISO_Impact

* [Health and care](../RiskISO/PBN__RiskISO_Purpose_0)

## Property: has_RiskTechnology

* [rapid and reliable covid-19 testing technologies](../Technology/PBN__Technology_794)

## Property: has_RiskSubject

* [employees](../Stakeholder/PBN__Stakeholder_220)
* [visitors](../Stakeholder/PBN__Stakeholder_118)
* [general population](../Stakeholder/PBN__Stakeholder_9)

## Property: has_RiskType

* [social](../RiskType/PBN__RiskType_2)

## Property: has_RiskISO_Purpose

* [Well-being](../RiskISO/PBN__RiskISO_Impact_1)

## Property: has_RiskOwner

* [employers](../Stakeholder/PBN__Stakeholder_180)
* [healthcare institutions](../Stakeholder/PBN__Stakeholder_269)
* [public health authorities](../Stakeholder/PBN__Stakeholder_0)

## Property: has_RiskMitigation

* [Implement regular and widespread symptom monitoring and testing, both symptomatic and asymptomatic](../RiskMitigation/PBN__RiskMitigation_2039)

## Property: has_RiskName

Increased risk of undetected infection and potential for outbreak spread

## Property: has_RiskDescription

Lack of effective symptom monitoring and testing strategies

## Property: has_RiskSource

* [ingram_covid-19_2021](../Article/PBN__Article_255)

## Property: has_RiskGBN

* [No](../RiskGBN/PBN__RiskGBN_0)

## Property: has_RiskHealth

* [physical](../RiskHealth/PBN__RiskHealth_0)

